Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors
Interventions: DRUG: Palbociclib 125mg and Ribociclib 600 mg
Sponsor: Namik Kemal University